ClinicalTrials.Veeva

Menu
Celerion | Phoenix Celerion CPU logo

Celerion | Phoenix Celerion CPU

Research site

Site insights

Top conditions

Top treatments

Itraconazole
Selpercatinib
Rifampin
LY3527723
Donepezil
Midazolam
Omeprazole
MGL-3196
Lansoprazole
Vedolizumab

Parent organization

This site is a part of Celerion

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Active trials

7 of 170 total trials

A Dose Calibration Study Comparing IkT-001Pro to Imatinib Mesylate 400mg

This study investigates the safety, tolerability and dose equivalence of drug IkT-001Pro in healthy volunteers (18 to 55 years old) in comparison to...

Active, not recruiting
CML
Drug: IkT-001Pro
Drug: Imatinib Mesylate

The purposes of this study are to:* Learn about the safety and tolerability of CK 4021586 after a single dose and multiple doses in healthy subjects....

Enrolling
Healthy Participants
Drug: CK-4021586
Drug: Placebo for CK-4021586

The goal of the study is to see what happens to levels of midazolam and digoxin in a person's body over time (a pharmacokinetic or PK study). Researc...

Active, not recruiting
Non-small Cell Lung Cancer
Drug: Digoxin
Drug: MK-1084

This study is conducted to determine the Bioequivalence of Ruxolitinib XR 55 mg Tablets With Ruxolitinib IR Tablets Administered Orally in Healthy Pa...

Enrolling
Healthy Participants
Drug: Ruxolitinib XR
Drug: Ruxolitinib IR

Researchers have designed a study medicine called bomedemstat (MK-3543) as a new way to treat certain rare blood diseases.The purpose of this study i...

Enrolling
Healthy
Drug: bomedemstat
Drug: carbamazepine

A First-in-Human 2-part, randomized, double-blind, placebo-controlled, single ascending dose, multiple ascending dose, and food effect, investigation...

Not yet enrolling
Healthy Adult Participants
Drug: Placebo
Drug: PORT-77

This study in healthy volunteers will provide a basis for evaluation of TRL345 as a first in human study, specifically, important safety, tolerabilit...

Enrolling
Healthy Volunteers
Drug: TRL345, a human monoclonal antibody

Trial sponsors

Takeda logo
Janssen (J&J Innovative Medicine) logo
Lilly logo
Vertex Pharmaceuticals logo
C
Acerta Pharma logo
C
Corcept Therapeutics logo
Madrigal Pharmaceuticals logo
Merck Sharp & Dohme (MSD) logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems